Black Rock Inc. Exact Sciences Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Black Rock Inc. holds 12,065,858 shares of EXAS stock, worth $595 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,065,858
Previous 11,376,096
6.06%
Holding current value
$595 Million
Previous $786 Million
35.11%
% of portfolio
0.01%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding EXAS
# of Institutions
671Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$876 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$781 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$707 Million0.18% of portfolio
-
State Street Corp Boston, MA6.68MShares$330 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$259 Million0.03% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.73B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...